127 related articles for article (PubMed ID: 37277268)
1. Treatment-Induced Bone Marrow Enhancement at MRI in Breast Cancer Patients Receiving Granulocyte-Colony Stimulating Factor Adjunct to Chemotherapy.
Sorin V; Bokov I; Haisraely O; Ben-David MA; Faermann R; Sklair-Levy M
Acad Radiol; 2023 Sep; 30 Suppl 2():S9-S15. PubMed ID: 37277268
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte colony-stimulating factor (G-CSF)-supported chemotherapy on MR imaging of normal red bone marrow in breast cancer patients with focal bone metastases.
Ciray I; Lindman H; Aström GK; Wanders A; Bergh J; Ahlström HK
Acta Radiol; 2003 Sep; 44(5):472-84. PubMed ID: 14510752
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.
Minutoli F; Pergolizzi S; Blandino A; Mormina E; Amato E; Gaeta M
Radiol Med; 2020 Mar; 125(3):280-287. PubMed ID: 31823293
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings.
Hartman RP; Sundaram M; Okuno SH; Sim FH
AJR Am J Roentgenol; 2004 Sep; 183(3):645-53. PubMed ID: 15333351
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
8. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
[TBL] [Abstract][Full Text] [Related]
9. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
[TBL] [Abstract][Full Text] [Related]
10. The effects of granulocyte colony-stimulating factor on MR images of bone marrow.
Gu L; Madewell JE; Aslam R; Mujtaba B
Skeletal Radiol; 2019 Feb; 48(2):209-218. PubMed ID: 30091008
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
12. Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy.
Fletcher BD; Wall JE; Hanna SL
Radiology; 1993 Dec; 189(3):745-51. PubMed ID: 7694312
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor.
Ryan SP; Weinberger E; White KS; Shaw DW; Patterson K; Nazar-Stewart V; Miser J
AJR Am J Roentgenol; 1995 Oct; 165(4):915-20. PubMed ID: 7545864
[TBL] [Abstract][Full Text] [Related]
15. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
[TBL] [Abstract][Full Text] [Related]
16. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer.
Danova M; Rosti V; Mazzini G; De Renzis MR; Locatelli F; Cazzola M; Riccardi A; Ascari E
Int J Cancer; 1995 Nov; 63(5):646-51. PubMed ID: 7591280
[TBL] [Abstract][Full Text] [Related]
18. Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors.
Altehoefer C; Bertz H; Ghanem NA; Langer M
J Magn Reson Imaging; 2001 Aug; 14(2):141-6. PubMed ID: 11477672
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
Orazi A; Cattoretti G; Schiró R; Siena S; Bregni M; Di Nicola M; Gianni AM
Blood; 1992 May; 79(10):2610-9. PubMed ID: 1586713
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic problems in magnetic resonance tomography of the bone marrow in patients with malignomas under G-CSF therapy].
Layer G; Sander W; Träber F; Block W; Ko Y; Ziske CG; König R; Vahlensieck M; Schild HH
Radiologe; 2000 Aug; 40(8):710-5. PubMed ID: 11006941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
